Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK)
of 2 different TR-701 oral formulations (free acid phosphate powder in capsule and di-sodium
phosphate salt formulated capsule) after single doses in normal healthy adult subjects and to
assess the relative bioavailability of TR-701 free acid phosphate powder in capsule
formulation compared to di-sodium phosphate salt formulated capsule.